title: Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
authors.forename: Mike P
authors.initials: MP
authors.lastname: Wattjes
authors.forename: Lonneke
authors.initials: L
authors.lastname: Verhoeff
authors.forename: Willemijn
authors.initials: W
authors.lastname: Zentjens
authors.forename: Joep
authors.initials: J
authors.lastname: Killestein
authors.forename: Erik T
authors.initials: ET
authors.lastname: van Munster
authors.forename: Frederik
authors.initials: F
authors.lastname: Barkhof
authors.forename: Jeroen J J
authors.initials: JJ
authors.lastname: van Eijk
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000098:blood supply / Q000473:pathology; D002536:Cerebral Arteries / Q000473:pathology; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007089:Image Enhancement; D007090:Image Interpretation, Computer-Assisted; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced* / Q000175:diagnosis* / Q000188:drug therapy; D007262:Infusions, Intravenous; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis / Q000188:drug therapy*; D000069442:Natalizumab; D009460:Neurologic Examination / Q000187:drug effects; D010951:Plasma Exchange
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab; D008775:Methylprednisolone
keywords: Infectious Diseases; MRI; Multiple Sclerosis